Two Drugs Approved for NPM1-Mutated Leukemia

(MedPage Today) — The FDA has approved two targeted menin inhibitors for the treatment of relapsed/refractory NPM1-mutated acute myeloid leukemia (AML).
Ziftomenib (Komzifti) was approved on Thursday for adults with relapsed/refractory NPM1-mutated…

Source link : https://www.medpagetoday.com/hematologyoncology/leukemia/118506

Author :

Publish date : 2025-11-13 19:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Two Drugs Approved for NPM1-Mutated Leukemia

Second Menin Inhibitor Approved for Mutated R/R AML

RFK Jr. ‘Diss Track’; Med Student Qualifies for Olympic Trials; Infant Formula PSA

Related Posts

Alberta’s Physicians Resist Restrictions on Transgender Care

New Moms With Disabilities Show Low Receipt of Care Talks

IVF Tests and Treatments Are Backed by Varying Evidence

Coffee May Slow Biological Aging in Severe Mental Illness

Probiotic Blend Benefits Patients With Nonconstipated IBS

Hearing in Luigi Mangione’s State Murder Case Sheds New Light on His Arrest

Alberta’s Physicians Resist Restrictions on Transgender Care

New Moms With Disabilities Show Low Receipt of Care Talks

IVF Tests and Treatments Are Backed by Varying Evidence

Coffee May Slow Biological Aging in Severe Mental Illness

Probiotic Blend Benefits Patients With Nonconstipated IBS

Hearing in Luigi Mangione’s State Murder Case Sheds New Light on His Arrest

At-Home HPV Sampling Endorsed in ACS Cervical Cancer Screening Guidelines

‘Freebirth’ Movement Is Dangerous to Moms but Reflects Real Concerns, Ob/Gyns Say

Categories

Archives